Join us at WCPGHAN 2024 in Buenos Aires (December 4-7) to explore how we're elevating infant health with purpose-led solutions in early life nutrition. Visit booth #18 to discover our expert-powered synbiotic innovations combining Human Milk Oligosaccharides (HMOs) and specific probiotic strains that are transforming infant nutrition development.
Don't miss our WCPGHAN symposium with Dr. Lars Bode on ‘Synbiotics – Unlocking synergies of HMOs and probiotics for infant health & development’, on Friday 6th from 12:30-13:30, where we'll explore the latest breakthroughs in early life nutrition science.
Want to know more about how our early life nutrition innovations and end-to-end capabilities can help you give infants the best start in life? Book a meeting with one of our experts or read on to learn more.
The future of early life nutrition is here. At WCPGHAN 2024, discover how our groundbreaking partnership with Lallemand Health Solutions combines HMOs with Expert'Biotic probiotic baby strains to support health and development in the first 2,200 days of life.
When breastfeeding isn't possible, our synergistic synbiotic solutions help bring the composition of the infant gut microbiome closer to that of breastfed infants. By combining HMOs that act as prebiotic agents with specific probiotic strains that utilize them, we're creating solutions that strengthen gut barrier function, support immune system development, and promote healthy gut brain axis development.
Join Dr. Lars Bode, Director of the Human Milk Institute at the University of California, on Friday December 6th from 12:30-13:30 in Room E, as he explores how specific HMOs can selectively promote the growth of probiotic strains to enhance infant health outcomes.
Register for the symposium to discover how these innovations are helping bring the composition and functionality of infant nutrition closer to breast milk, the gold standard for infant nutrition.
HMOs are complex carbohydrate structures and the third most abundant solid component in human milk. Through pioneering research and development, we can now incorporate these vital compounds into infant nutrition solutions to better mirror the composition and functionality of breast milk.
Clinical research shows that HMOs play a crucial role during the first thousand days of life, helping to nourish beneficial gut bacteria, support immune system development, and protect against harmful microbes. With over 200 HMO structures identified in breast milk, our leading HMO portfolio offers opportunities to enhance infant nutrition in ways previously not possible.
Explore key insights from the landmark DO-HEALTH trial on slowing biological aging, and what they mean for supplement innovators in the healthy longevity space.
Discover five benefits of a world-class premix manufacturer, from greater traceability to faster development timelines.
Discover how dsm-firmenich is transforming global nutrition through partnerships, and science-based innovations to fight micronutrient deficiencies.
Have an idea for a new project, a groundbreaking innovation, or a need for expert services? Let’s talk.
Don’t just take our word for it. Discover how our solutions can support your product development journey.
Customized blends of functional ingredients in one single, efficient premix.
Streamline your product development process and get to market faster.
From trade shows to conferences and other industry events, find out where you can meet us next.
Talking Nutrition, Health & Care
Explore new science, consumer insights, industry news and more in our latest articles.
Discover educational whitepapers, webinars, publications and technical information.
Request samples, place orders and view product documentation.